KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Oct 01, 2026 - 3:59PM >>  ABB India 6854.4  [ 1.49% ]  ACC 1182.2  [ -1.86% ]  Ambuja Cements 363  [ -2.46% ]  Asian Paints 2406.25  [ -0.29% ]  Axis Bank 1214  [ -0.98% ]  Bajaj Auto 10069.85  [ -7.28% ]  Bank of Baroda 231.75  [ 0.32% ]  Bharti Airtel 1741  [ -0.98% ]  Bharat Heavy 422  [ 1.69% ]  Bharat Petroleum 301  [ -0.66% ]  Britannia Industries 4794.85  [ -0.33% ]  Cipla 1346.85  [ -0.23% ]  Coal India 421.5  [ -0.67% ]  Colgate Palm 1735  [ -2.20% ]  Dabur India 377  [ -1.05% ]  DLF 662.6  [ -1.40% ]  Dr. Reddy's Lab. 1200.1  [ -2.90% ]  GAIL (India) 170.8  [ 0.06% ]  Grasim Industries 2971.85  [ -3.12% ]  HCL Technologies 1246  [ 1.38% ]  HDFC Bank 719.35  [ 1.36% ]  Hero MotoCorp 5173  [ -1.22% ]  Hindustan Unilever 1841  [ -2.17% ]  Hindalco Industries 944.4  [ 0.22% ]  ICICI Bank 1305.5  [ -1.29% ]  Indian Hotels Co. 716.15  [ -1.76% ]  IndusInd Bank 880  [ -1.97% ]  Infosys 1035  [ 4.02% ]  ITC 257  [ -2.56% ]  Jindal Steel 1099  [ -2.92% ]  Kotak Mahindra Bank 419.8  [ 0.53% ]  L&T 3685.5  [ -1.85% ]  Lupin 2029  [ -0.64% ]  Mahi. & Mahi 2851.05  [ -3.27% ]  Maruti Suzuki India 11400  [ -4.59% ]  MTNL 24.7  [ 7.30% ]  Nestle India 1303.8  [ -0.63% ]  NIIT 85.25  [ -0.70% ]  NMDC 75  [ -2.33% ]  NTPC 316.7  [ -1.65% ]  ONGC 222.7  [ -1.02% ]  Punj. NationlBak 109.9  [ -3.09% ]  Power Grid Corpn. 254.65  [ -2.23% ]  Reliance Industries 1166  [ -1.81% ]  SBI 954  [ -0.70% ]  Vedanta 251.9  [ -2.70% ]  Shipping Corpn. 267.15  [ -1.24% ]  Sun Pharmaceutical 1810  [ -0.55% ]  Tata Chemicals 607.9  [ -0.54% ]  Tata Consumer 949  [ -0.42% ]  Tata Motors Passenge 280  [ -1.70% ]  Tata Steel 179.1  [ -3.01% ]  Tata Power Co. 350  [ -2.51% ]  Tata Consult. Serv. 2079.3  [ 1.43% ]  Tech Mahindra 1539  [ 0.40% ]  UltraTech Cement 10799  [ -1.60% ]  United Spirits 1338.2  [ -0.87% ]  Wipro 159.5  [ 0.69% ]  Zee Entertainment 71.9  [ -3.48% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

HINDUSTAN BIO SCIENCES LTD.

01 October 2026 | 04:01

Industry >> Trading & Distributors

Select Another Company

ISIN No INE597C01021 BSE Code / NSE Code 532041 / HINDBIO Book Value (Rs.) 0.70 Face Value 2.00
Bookclosure 30/09/2024 52Week High 10 EPS 0.00 P/E 0.00
Market Cap. 7.53 Cr. 52Week Low 5 P/BV / Div Yield (%) 10.57 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Established in 2000, Hindustan Bio Sciences Limited (HBSL) is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The company initially commenced operations by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.

In the year 2007 the company obtained the import license from Genetic Engineering Approval Committee (GEAC) for a nephrology product "Recombinant Human Erythropotien" after conducting clinical trials of the same. The company has been marketing the niche drug extensively ever since.

The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe.

2001 - The Company has entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd (R&T agents) for dematerialisation.

2004 -Hindustan Bio bags GEAC nod recombinant human erythropoietin

2005 -Hindustan Bio Sciences Ltd has received an order for Antiretroviral drug for a value of Rs 269.30 million from China.